Holen Sie sich die Stockscreener-App
28.83
3.90%
-1.17
Handel nachbörslich:
28.83
Schlusskurs vom Vortag:
$30.00
Offen:
$29.79
24-Stunden-Volumen:
689.24K
Relative Volume:
1.78
Marktkapitalisierung:
$1.47B
Einnahmen:
$400.79M
Nettoeinkommen (Verlust:
$-35.58M
KGV:
-40.69
EPS:
-0.7085
Netto-Cashflow:
$-15.09M
1W Leistung:
+2.78%
1M Leistung:
-3.84%
6M Leistung:
-26.73%
1J Leistung:
-7.63%
1-Tages-Spanne:
$28.79
$30.21
1-Wochen-Bereich:
$27.91
$30.21
52-Wochen-Spanne:
$27.55
$40.71
Immunocore Holdings Plc Adr Stock (IMCR) Company Profile
Firmenname
Immunocore Holdings Plc Adr
Sektor
Branche
Telefon
01235 5430281
Adresse
90 PARK DRIVE, OXFORDSHIRE
Compare IMCR vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMCR
Immunocore Holdings Plc Adr
|
28.83 | 1.53B | 400.79M | -35.58M | -15.09M | -0.7085 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Herabstufung | Jefferies | Buy → Hold |
| 2026-01-07 | Hochstufung | UBS | Sell → Buy |
| 2025-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-18 | Fortgesetzt | Guggenheim | Neutral |
| 2025-08-25 | Fortgesetzt | Jefferies | Buy |
| 2025-05-27 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-11-11 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Sell |
| 2024-10-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-04-29 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-09-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-09-13 | Eingeleitet | Needham | Buy |
| 2023-08-16 | Eingeleitet | CapitalOne | Overweight |
| 2023-07-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-03-30 | Eingeleitet | Guggenheim | Buy |
| 2023-03-24 | Eingeleitet | Bryan Garnier | Buy |
| 2022-12-16 | Hochstufung | Goldman | Neutral → Buy |
| 2022-11-30 | Eingeleitet | Barclays | Overweight |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-09-08 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-08-08 | Eingeleitet | Cowen | Outperform |
| 2022-08-02 | Eingeleitet | BTIG Research | Buy |
| 2022-02-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-20 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Neutral |
| 2021-03-02 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-02 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Immunocore Holdings Plc Adr Aktie (IMCR) Neueste Nachrichten
69,271 ADRs sale scheduled by Immunocore (NASDAQ: IMCR) - Stock Titan
Here's Why You Should Add Altimmune Stock to Your Portfolio Now - TradingView
Wall Street Analysts Think Immunocore (IMCR) Could Surge 111.53%: Read This Before Placing a Bet - Yahoo Finance
Immunocore Holdings (NASDAQ: IMCR) plans 65,000 ADR cashless sale - Stock Titan
Is it a Good Idea to Invest in Stoke Therapeutics Stock Now? - TradingView
ATRA Stock Shoots Up 82% in a Month: Here's What You Should Know - TradingView
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know - TradingView
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study - TradingView
FDA Accepts Viatris' NDA for Fast-Acting Non-Opioid Pain Therapy - TradingView
Roche's Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer - TradingView
CRMD Q1 Earnings Beat on DefenCath Momentum, Guidance Raised - TradingView
T. Rowe Price (IMCR) holds 1.89M ADRs, files Schedule 13G/A amendment - Stock Titan
Immunocore Holdings stock (GB00BL963Z95): Recent price dip amid biotech trends - AD HOC NEWS
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y - TradingView
Mizuho cuts Immunocore stock price target to $34 on trimmed revenue - Investing.com
IMCR SEC FilingsImmunocore Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Immunocore reports first quarter financial results and provides a business update - GlobeNewswire Inc.
Hussman Strategic Advisors Inc. Purchases Shares of 42,000 Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Immunocore (IMCR) upgraded to strong buy: Here's why - MSN
Q1 Earnings Forecast for Immunocore Issued By HC Wainwright - MarketBeat
Massachusetts Financial Services Co. MA Trims Holdings in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat
Immunocore (NASDAQ: IMCR) outlines 10 resolutions for 2026 hybrid AGM - Stock Titan
H.C. Wainwright reiterates Immunocore stock rating citing KIMMTRAK penetration - Investing.com
Immunocore Details KIMMTRAK Growth, TCR Platform and Key Readouts at Needham Conference - Yahoo Finance
Immunocore Holdings Plc (NASDAQ: IMCR) plans same‑day cashless sale of 25,000 ADRs - Stock Titan
Immunocore Holdings stock: What you need to know for smart investing now - AD HOC NEWS
Immunocore Holdings plc (IMCR) stock price, news, quote and history - uk.finance.yahoo.com
Immunocore Holdings stock: Precision Oncology Leader with ImmTAC Innovation - AD HOC NEWS
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Short Interest Down 15.4% in March - MarketBeat
Jefferies reiterates Hold on Immunocore stock amid competitor data By Investing.com - Investing.com South Africa
Jefferies reiterates Hold on Immunocore stock amid competitor data - Investing.com
Immunocore (IMCR) upgraded to strong buy: Here's what you should know - MSN
Jefferies downgrades Immunocore stock rating on revenue concerns - Investing.com
Jefferies downgrades Immunocore stock rating on revenue concerns By Investing.com - Investing.com South Africa
Insider sells 11,832 ADRs at Immunocore (NASDAQ: IMCR) in cashless exercise - Stock Titan
Immunocore at Leerink Conference: Strategic Growth and Innovation - Investing.com
What is HC Wainwright's Estimate for Immunocore Q1 Earnings? - MarketBeat
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
T. Rowe Price (IMCR) lists 3,041,904 ADRs, a 6.0% stake in Immunocore - stocktitan.net
FY2027 EPS Estimates for Immunocore Cut by HC Wainwright - MarketBeat
Immunocore (NASDAQ:IMCR) Price Target Raised to $75.00 at Needham & Company LLC - Defense World
Immunocore Q4 Earnings Call Highlights - Yahoo Finance
Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates - Investing.com South Africa
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up - Finviz
JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations - Finviz
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y - Finviz
Earnings call transcript: Immunocore Holdings Q4 2025 reveals strong growth, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Immunocore Holdings Q4 2025 reveals strong growth, stock dips - Investing.com India
Finanzdaten der Immunocore Holdings Plc Adr-Aktie (IMCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.98%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):